Search results - 10 results
Manufacture and control of vaccine adjuvants from OMCL perspective
Publication Type: Scientific poster, presentation or proceeding Authors: L. Tesolin Source: Seminaire ULB Pharmacien d'industrie, ULB, ULB pharmacie (2022) Keywords: Adjuvants manufacture OMCL ...
The vaccine Batch release procedure in Europe
Publication Type: Scientific poster, presentation or proceeding Authors: L. Tesolin Source: Seminaire ULB Pharmacien d'industrie, ULB, ULB pharmacie (2022) Keywords: batch release Europe OMCL ...
Analysis of illegal peptide drugs via HILIC-DAD-MS.
p.562-571 (2017) Abstract: Biopharmaceuticals have established themselves as highly efficient medicines, and are still one of the fastest growing parts of the health-product industry. Unfortunately, the ...
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).
the European Federation of Pharmaceutical Industries Association (EFPIA) hosted a multistakeholder workshop on dose finding (London 4-5 December 2014). Some methodologies that could constitute a toolkit ...
Commentary on the MID3 Good Practices Paper.
the development and regulatory assessment of medicines. In the 2011 EMA — European Federation of Pharmaceutical Industries and Associations (EFPIA) Workshop on Modelling and Simulation, European ...
Chromatographic fingerprinting as a strategy to identify regulated plants in illegal herbal supplements.
herbal alternatives. Furthermore, herbal supplements are increasingly gaining popularity in industrialized countries and, as a consequence, quality control is a highly important issue. Unfortunately, this ...
Detection and risk evaluation of counterfeit medicines based on physico-chemical properties: the fingerprint and chemometrics approach
physico-chemical properties risk evaluation Abstract: Counterfeit medicines pose a global threat to public health; both developing and industrialized countries are exposed to pharmaceutical forgery. These products ...
Regulatory panel discussion. An interactive panel discussion with key authoritative figures from various European regulatory agencies focusing on the regulation of the biologics industry.
Affect an challenge CHALLENGES Discussion European Industries Industry ON production regulation Regulatory use Service: Qualité des vaccins et produits sanguins Kwaliteit van vaccins en bloedproducten ...
Classification trees based on infrared spectroscopic data to discriminate between genuine and counterfeit medicines
a growing threat for public health in the developing countries but also more and more in the industrial world. In literature several analytical techniques were applied in order to discriminate between genuine ...
Non-sterile pharmaceutical water: source of life and/or potential carrier for opportunistic pathogens
world. Evidently, this molecule is also one of the major resources utilized by the pharmaceutical industry. Water can be present as an excipient or might be used for reconstitution of products, during ...